Doximity, Inc. (NYSE: DOCS) released its 2026 Physician Compensation Report, revealing that nearly a quarter of US physicians expect artificial intelligence to increase their total compensation within the next year.

The digital platform for medical professionals found that 23% of surveyed doctors anticipate higher earnings from AI adoption in the next 12 months. A larger majority, 67%, believe that staying current with AI tools will provide a meaningful earnings advantage over peers who do not adopt the technology.

What the Numbers Show

The data highlights a divergence between workforce strain and technological optimism. While 82% of physicians reported being overworked in a June 2026 poll, a significant portion views AI as leverage rather than a threat. Specifically, 46% of overworked physicians are eyeing early retirement, up from 34% previously, yet 39% report that AI proficiency is now a factor in hiring and promotion decisions for their specialty.

Workforce Strain and Compensation Trends

The physician shortage continues to impact clinical practice, with 85% of doctors stating it has affected their work. 76% reported that systemic pressures compromised the quality of care provided in the past 12 months. Among those feeling overworked, 66% are considering a career change.

Broader compensation metrics show moderating growth:

The gender pay gap held steady at 26% for the second consecutive year. The disparity between surgical specialists and primary care physicians widened, with specialists now earning 90.1% more than primary care providers, compared to 87.3% in 2024.

AI as Professional Currency

AI proficiency is emerging as a critical career asset. At least 39% of physicians indicated that AI skills influence hiring and promotion decisions, including 15% who described it as a "major" or "moderate" factor. Doximity, which has over 85% of US physicians as members, bases these findings on salary data from more than 23,000 responses collected in 2025 and new survey findings from June 2026.

Doximity Inc. (NYSE: DOCS) reported fiscal first-quarter results that exceeded revenue expectations, driven by robust adoption of its artificial intelligence products and an expanded total addressable market in healthcare. The digital healthcare company posted revenue of $156.6 million, up 7% year over year, beating the analyst consensus estimate of $151.7 million. This performance reflects a broader commercial opportunity unlocked by AI, which CEO Jeff Tangney described as a "real surprise and upside" for the business. The positive reception was amplified by a short squeeze, with shares surging 34.29% to $27.74 on Friday, given that over 16% of the public float was sold short.

The company’s adjusted EBITDA totaled $74.8 million, representing a 48% margin. Earnings per share were 29 cents, slightly below the consensus estimate of 30 cents. Despite the minor miss on EPS, the strong top-line growth and margin expansion underscored the effectiveness of Doximity’s strategy to integrate AI into clinical workflows. Tangney noted that AI is "up-leveling our business across the board," enabling deeper engagement with senior executives at pharmaceutical companies.

AI Products Drive Growth

Doximity’s clinical AI assistant, Doximity Ask, emerged as a key growth driver, achieving the lowest clinical error rates and highest safety ratings among tested U.S.-based models in the NOHARM benchmark. The product recorded a 4.8% error rate compared to 13.6% for Anthropic’s leading model. This performance has facilitated broader adoption across health systems, with 165 health system clients now using Doximity’s AI offerings. Workflow active prescriber growth exceeded 30% year over year, while AI Search queries increased more than 25% sequentially.

Financial Outlook and Investment Strategy

CFO Matt Sonefeldt stated that stronger-than-expected AI adoption by clinicians prompted Doximity to increase AI investments during fiscal 2027 to support long-term growth opportunities. The company ended the quarter with 127 pharmaceutical and hospital customers generating more than $500,000 in annual subscription revenue on a trailing 12-month basis.

For the fiscal second quarter, Doximity expects revenue of $170 million to $171 million, compared with the analyst consensus estimate of $171.9 million. The company raised its full-year fiscal 2027 revenue guidance to a range of $671 million to $681 million, up from the prior outlook of $664 million to $676 million. This updated forecast exceeds the consensus estimate of approximately $670.3 million.

What the Numbers Show

The divergence between the slight miss on earnings per share and the significant beat on revenue highlights a strategic shift in capital allocation. While operational efficiency remains high with a 48% adjusted EBITDA margin, the company is actively reinvesting in AI infrastructure to capture larger commercial opportunities. The sequential jump in AI Search queries (>25%) alongside record engagement suggests that the initial investment phase is yielding tangible user adoption metrics, validating the decision to raise full-year guidance despite near-term pressure on bottom-line estimates.